Clinical Trial Update: BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing beta-lactam continuous versus intermittent infusion in critically ill pneumonia patients; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: University of Florida | Conditions: Pneumonia | Phase 4 | Status: TERMINATED | Results posted: 2023-12-12